Amnion nodosum

From WikiMD's WELLNESSPEDIA


Amnion nodosum
Synonyms
Pronounce N/A
Specialty N/A
Symptoms Small nodules on the amnion
Complications Oligohydramnios, pulmonary hypoplasia
Onset During pregnancy
Duration
Types N/A
Causes Reduced amniotic fluid
Risks
Diagnosis Ultrasound, histopathology
Differential diagnosis
Prevention
Treatment
Medication
Prognosis Depends on underlying cause
Frequency Rare
Deaths N/A


Amnion Nodosum is a pathological condition that affects the amnion, the innermost layer of the placenta. It is characterized by the presence of nodules or granules on the amniotic surface of the placenta. These nodules are typically composed of squamous cells that have been shed from the fetus.

Etiology[edit]

The exact cause of amnion nodosum is not well understood. However, it is often associated with oligohydramnios, a condition characterized by a deficiency of amniotic fluid. This association suggests that amnion nodosum may be a response to an abnormal intrauterine environment.

Pathogenesis[edit]

The nodules in amnion nodosum are believed to be formed by the accumulation of squamous cells that have been shed from the fetal skin. These cells may accumulate due to a lack of amniotic fluid, which normally helps to disperse the cells throughout the amniotic cavity.

Clinical Significance[edit]

Amnion nodosum is often associated with poor fetal outcomes, including intrauterine growth restriction, premature birth, and stillbirth. However, it is not clear whether amnion nodosum is a cause of these outcomes, or simply a marker of an abnormal intrauterine environment.

Diagnosis[edit]

Amnion nodosum is typically diagnosed after birth, during examination of the placenta. The presence of nodules on the amniotic surface of the placenta is a characteristic finding.

Treatment[edit]

There is currently no specific treatment for amnion nodosum. Management is typically focused on addressing the underlying cause, such as treating oligohydramnios.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.